COVID-19 vaccines Current Affairs, GK & News

Nasal Covid Vaccine Gets Regulatory Nod for further trials

India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology. Key Points Nasal Covid Vaccine has been developed by Bharat Biotech. Vaccine has successfully completed Phase 1 clinical trial in age groups of 18 to 60 years. According to the officials, doses ..

Month: 

Category: 

Topics: 

Japan to help India build Vaccine Cold Chain Facilities

Japan is all set to provide India a $10 million assistance for building cold chain facilities to safely store covid-19 vaccines. Key Points Japan will provide this assistance to India to build cold chain equipment including medical equipment like cold-storage facilities. Cold storage facilities will be built as ‘Last One Mile Support’. These facilities will ..

Month: 

Category: 

Topics: 

Delhi’s ‘Jahan Vote, Wahan Vaccination’ Campaign

Delhi government launched a vaccination campaign ‘Jahan Vote, Wahan Vaccination’ to vaccinate people of Delhi against Covid-19. Under the campaign, people aged 45 and above will be given vaccine at the polling booths. Highlights While launching the campaign, Chief Minister Arvind Kejriwal highlighted, jabs will be provided to people above 45 years at places where ..

Month: 

Category: 

Topics: 

COVAXIN trial starts on children

Trial of COVAXIN, a COVID-19 vaccine by Bharat Biotech, on children below 18 years was started at All India Institute of Medical Sciences (AIIMS), Patna. Background Trail was started following a nod given on May 11 by Drugs Controller General of India (DCGI) to conduct clinical trials of Covaxin. COVAXIN was approved by DCGI, for ..

Month: 

Category: 

Topics: 

Pfizer-BioNTech to provide 2 billion Covid-19 vaccine to Poor Nations

In a bid to fulfil the international calls for vaccine solidarity, American pharmaceutical company, Pfizer and German company, BioNTech have pledged to provide 2 billion doses of Covid-19 vaccine to poor countries in middle-income and low-income countries in next 18 months. This announcement was made at the global health summit hosted by Italy. Highlights Both ..

Month: 

Category: 

Topics: